Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Oncology Letters|February 6, 2018
Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancerYin-Ju Chen, Chia-Chun Kuo, Lai-Lei Ting, et al.
Biomedical Journal|July 10, 2025
Drug Repurposing Targeting miRNA-mRNA Networks to Mitigate Areca Nut-Induced Head and Neck CancerHung-Han Huang, Joseph T Chang, Guo-Rung You, et al.
Clinical Biochemistry|December 9, 2014
Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancerYa-Ching Lu, Joseph Tung-Chieh Chang, Yu-Chen Huang, et al.
International Journal of Nanomedicine|March 30, 2023
Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization TreatmentYa-Chun Chu, Hsu-Wei Fang, Yu-Yi Wu, et al.
ACS Applied Materials & Interfaces|October 24, 2024
Drug-Free Mesoporous Silica Nanoparticles Enable Suppression of Cancer Metastasis and Confer Survival Advantages to Mice with Tumor XenograftsYu-Tse Lee, Si-Han Wu, Cheng-Hsun Wu, et al.
Plos One|June 6, 2013
DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathwayYin-Ju Chen, Li-Yu Lee, Yin-Ka Chao, et al.
Biomaterials|March 2, 2025
Platelet-derived extracellular vesicle drug delivery system loaded with kaempferol for treating corneal neovascularizationGuei-Sheung Liu, Huai-An Chen, Che-Yi Chang, et al.
Clinical Chemistry and Laboratory Medicine|March 18, 2015
Fascin is a circulating tumor marker for head and neck cancer as determined by a proteomic analysis of interstitial fluid from the tumor microenvironmentLi-Yu Lee, Yin-Ju Chen, Ya-Ching Lu, et al.
Cancers|January 21, 2022
A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic LesionsFang-Chi Hsu, Hsin-Lun Lee, Yin-Ju Chen, et al.
Radiation Oncology (London, England)|October 14, 2011
GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapyChien-Yu Lin, Ting-Yang Lin, Hung-Ming Wang, et al.
Pageof 6